Abstract: The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment.

Abstract: Compositions and methods for inhibiting gastrointestinal absorption of phosphate in a subject are provided. Such compositions are composed of enteric-coated, sustained-release calcium carbonate, which find application in the prevention or treatment of hyperphosphatemia.

Abstract: Compositions and methods for improving renal function with Streptococcus probiotic bacteria selected for converting nitrogenous waste into non-toxic compounds in vivo are provided. By reducing the levels of nitrogenous wastes, the instant compositions reduce kidney burden.

Abstract: The present invention provides a composition comprising prebiotic and probiotic components and is used to reduce elevated levels of nitrogenous waste products and to promote a healthy bowel microenvironment.

Abstract: The present invention provides compositions for consumption by both animals and humans for the maintenance of a healthy gastrointestinal tract, the probiotic composition is efficacious in removing toxic nitrogenous by-products caused by chemotherapy and dietary imbalances such as high protein diets. The compositions of the present invention are also useful for delaying the onset of illness in patients with metabolic syndromes such as borderline diabetics or hypertension.

Abstract: The present invention provides a food or nutritional product for consumption by individuals who want to maintain a healthy gastrointestinal tract, the probiotic composition is efficacious in removing toxic nitrogenous by-products of metabolism. Embodiments of the invention further include health bars yogurt, yogurt based products and foods that contain one or more vitamins or minerals, in addition to a carbohydrate, fats and protein components.

Abstract: The present invention provides compositions and methods of using these compositions for enteric dialysis to treat renal, hepatic and gastrointestinal diseases by eliminating toxins and other metabolic waste products and reducing or retarding undesirable bacterial over growth. The compositions of the present invention comprise a probiotic. These compositions are useful in treating renal and hepatic diseases and bacterial overgrowth in the gastrointestinal tract.

Abstract: Microencapsulated and/or enteric coated compositions containing a mixture of sorbents with specific adsorption affinities for uremic toxins including ammonia, urea, creatinine, phenols, indoles, and middle molecular weight molecules and a bacterial source which metabolizes urea and ammonia are provided. Also provided are methods of using these compositions to alleviate symptoms of uremia in patients.

Abstract: Microencapsulated and/or enteric coated compositions containing a mixture of probiotics, prebiotics and ammoniaphilic bacteria with high urease activity with or without sorbents with specific adsorption affinities for uremic toxins such as creatinine, uric acid, phenols, indoles, middle molecular weight molecules and inorganic phosphate and water absorbents are provided. Also provided are methods of alleviating symptoms of uremia in a patient which comprises administering orally to a patient suffering from uremia a microencapsulated and/or enteric-coated composition.

Abstract: Microencapsulated and/or enteric coated compositions containing a mixture of sorbents with specific adsorption affinities for uremic toxins including ammonia, urea, creatinine, phenols, indoles, and middle molecular weight molecules and a bacterial source which metabolizes urea and ammonia are provided. Also provided are methods of using these compositions to alleviate symptoms of uremia in patients.